Study Director/Scientist, Preclinical In Vivo Oncology
Crown Bioscience, Inc. (Taicang)
About this role
The Study Director/Scientist at Crown Bioscience North Carolina oversees the design, execution, and analysis of in vivo pharmacology studies, collaborating with internal teams and external partners. They play a key role in mentoring staff and ensuring high-quality scientific data delivery.
Skills
About Crown Bioscience, Inc. (Taicang)
crownbio.comN/A
Recent company news
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies
Nov 21, 2023
Narazaciclib, a novel multi-kinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models
Apr 19, 2024
Comparison of Continuous Glucose Monitoring between Dexcom G4 Platinum and HD-XG Systems in Nonhuman Primates ( Macaca Fascicularis
Aug 29, 2017
About Crown Bioscience, Inc. (Taicang)
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Crown Bioscience, Inc. (Taicang).
Salary
$115k – $158k
per year
More jobs at Crown Bioscience, Inc. (Taicang)
Similar Jobs
Senior Scientist 1, in Vivo Pharmacology
Crinetics Pharmaceuticals
Scientist, In Vivo Pharmacology
American Association of Physicists in Medicine
Principal Scientist, In Vivo Pharmacology
MSD
Sr. Scientist, In Vivo Pharmacology
American Association of Physicists in Medicine
Senior Associate Scientist- In Vivo Pharmacologist
Pfizer
Scientific Leader, In Vivo Pharmacology
GSK plc